NO305581B1 - Anvendelse av et benaktivt fosfonat i kombinasjon med et °strogenhormon, og preparat i enhetsdoseform for behandling av osteoporose - Google Patents
Anvendelse av et benaktivt fosfonat i kombinasjon med et °strogenhormon, og preparat i enhetsdoseform for behandling av osteoporoseInfo
- Publication number
- NO305581B1 NO305581B1 NO933044A NO933044A NO305581B1 NO 305581 B1 NO305581 B1 NO 305581B1 NO 933044 A NO933044 A NO 933044A NO 933044 A NO933044 A NO 933044A NO 305581 B1 NO305581 B1 NO 305581B1
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- osteoporosis
- hormone
- combination
- dosage form
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Removal Of Specific Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66177791A | 1991-02-26 | 1991-02-26 | |
PCT/US1992/000854 WO1992014474A1 (en) | 1991-02-26 | 1992-01-31 | Methods for the treatment of osteoporosis |
Publications (3)
Publication Number | Publication Date |
---|---|
NO933044L NO933044L (no) | 1993-08-26 |
NO933044D0 NO933044D0 (no) | 1993-08-26 |
NO305581B1 true NO305581B1 (no) | 1999-06-28 |
Family
ID=24655074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO933044A NO305581B1 (no) | 1991-02-26 | 1993-08-26 | Anvendelse av et benaktivt fosfonat i kombinasjon med et °strogenhormon, og preparat i enhetsdoseform for behandling av osteoporose |
Country Status (18)
Country | Link |
---|---|
US (1) | US6329354B1 (de) |
EP (1) | EP0573604B1 (de) |
JP (1) | JP3727332B2 (de) |
KR (1) | KR100240358B1 (de) |
AT (1) | ATE119777T1 (de) |
AU (1) | AU664368B2 (de) |
CA (1) | CA2101275C (de) |
CZ (1) | CZ282609B6 (de) |
DE (1) | DE69201725T2 (de) |
DK (1) | DK0573604T3 (de) |
ES (1) | ES2069424T3 (de) |
HU (1) | HU215124B (de) |
IE (1) | IE65963B1 (de) |
NO (1) | NO305581B1 (de) |
NZ (1) | NZ241717A (de) |
RU (1) | RU2113848C1 (de) |
SK (1) | SK90093A3 (de) |
WO (1) | WO1992014474A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2119337C1 (ru) * | 1992-03-21 | 1998-09-27 | Энтек Гезельшафт фюр Эндокринологише Технологи мбХ | Трансдермальный препарат продленного действия с антиостеопоротической активностью |
JPH08502287A (ja) * | 1992-10-09 | 1996-03-12 | ジ・アップジョン・カンパニー | 抗炎症剤としてのピリミジンビスホスホン酸エステルおよび(アルコキシメチルホスフィニル)アルキルホスホン酸 |
US6399592B1 (en) | 1992-12-23 | 2002-06-04 | Merck & Co., Inc. | Bishphosphonate/estrogen synergistic therapy for treating and preventing bone loss |
AU5953894A (en) * | 1992-12-23 | 1994-07-19 | Merck & Co., Inc. | Bisphosphonate/estrogen therapy for treating and preventing bone loss |
EP0697890A1 (de) * | 1993-05-15 | 1996-02-28 | Roche Diagnostics GmbH | Tablette mit verbesserter bioverfügbarkeit enthaltend dichlormethylendiphosphonsäure als wirkstoff |
US5554601A (en) * | 1993-11-05 | 1996-09-10 | University Of Florida | Methods for neuroprotection |
ES2262145T3 (es) * | 1994-12-28 | 2006-11-16 | Gador S.A. | Composicion anabolica para la masa osea que comprende olpadronato. |
DE19635883A1 (de) * | 1996-09-04 | 1998-03-05 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit einer Östriol enthaltenden Wirkstoffkombination |
US6376477B2 (en) | 1996-11-25 | 2002-04-23 | Merck & Co., Inc. | Combination of an agent that binds to the androgen receptor and a bisphosphonic acid in the prevention and/or treatment of diseases involving calcium or phosphate metabolism |
EP0949928A4 (de) * | 1996-11-25 | 2000-09-13 | Merck & Co Inc | Zusammen verabreichte androgene und diphosphonverbindungen zur behandlung von krankheiten |
US6692763B1 (en) * | 1998-11-19 | 2004-02-17 | The Regents Of The University Of California | Methods for treating postmenopausal women using ultra-low doses of estrogen |
AR013994A1 (es) * | 1998-10-30 | 2001-01-31 | Gador Sa | Procedimiento y preparaciones que modulan selectivamente la funcion del osteoblasto para la prevencion y tratamiento de las osteopatias fragilizantes. |
CN1217666C (zh) * | 1998-12-25 | 2005-09-07 | 东丽株式会社 | 白介素-6产生抑制剂 |
US6339078B1 (en) | 1999-07-20 | 2002-01-15 | University Of Florida Research Foundation, Inc. | Methods of prevention and treatment of ischemic damage |
US6326365B1 (en) | 1999-07-20 | 2001-12-04 | Apollo Biopharmaceutics, Inc. | Methods of prevention and treatment of ischemic damage |
US7335650B2 (en) | 2000-01-14 | 2008-02-26 | Sterix Limited | Composition |
US6653298B2 (en) | 2000-01-14 | 2003-11-25 | Sterix Limited | Composition |
US20040038946A1 (en) * | 2001-04-27 | 2004-02-26 | Wilson Lon J. | Fullerene-based drugs targeted to bone |
WO2009068567A1 (en) * | 2007-11-30 | 2009-06-04 | Novartis Ag | C2-c5-alkyl-imidazole-bisphosphonates |
US20160016982A1 (en) | 2009-07-31 | 2016-01-21 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
JP5852569B2 (ja) | 2009-07-31 | 2016-02-03 | タール ファーマシューティカルズ,インコーポレイテッド | 結晶化方法および生物学的利用能 |
US9169279B2 (en) | 2009-07-31 | 2015-10-27 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
US9340565B2 (en) | 2010-11-24 | 2016-05-17 | Thar Pharmaceuticals, Inc. | Crystalline forms |
WO2017208070A1 (en) | 2016-05-31 | 2017-12-07 | Grünenthal GmbH | Bisphosphonic acid and coformers with lysin, glycin, nicotinamide for treating psoriatic arthritis |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3553314A (en) | 1968-12-23 | 1971-01-05 | Procter & Gamble | Oral compositions for calculus retardation |
US3683080A (en) | 1970-08-28 | 1972-08-08 | Procter & Gamble | Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue |
EP0088462A3 (de) * | 1982-03-01 | 1984-06-06 | The Procter & Gamble Company | Entzündungshemmende und antirheumatische Zusammensetzung mit Gehalt an einem Organophosphonat und einem Steroiden |
EP0381296B1 (de) * | 1984-04-30 | 1994-11-30 | THE PROCTER & GAMBLE COMPANY | Ausrüstung für die Verwendung bei der Behandlung von Osteoporose |
US4761406A (en) | 1985-06-06 | 1988-08-02 | The Procter & Gamble Company | Regimen for treating osteoporosis |
IL86951A (en) | 1987-07-06 | 1996-07-23 | Procter & Gamble Pharma | Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them |
-
1992
- 1992-01-31 AU AU16433/92A patent/AU664368B2/en not_active Ceased
- 1992-01-31 CZ CS931755A patent/CZ282609B6/cs not_active IP Right Cessation
- 1992-01-31 SK SK900-93A patent/SK90093A3/sk unknown
- 1992-01-31 KR KR1019930702547A patent/KR100240358B1/ko not_active IP Right Cessation
- 1992-01-31 JP JP51158492A patent/JP3727332B2/ja not_active Expired - Lifetime
- 1992-01-31 ES ES92908494T patent/ES2069424T3/es not_active Expired - Lifetime
- 1992-01-31 WO PCT/US1992/000854 patent/WO1992014474A1/en active IP Right Grant
- 1992-01-31 DK DK92908494.5T patent/DK0573604T3/da active
- 1992-01-31 AT AT92908494T patent/ATE119777T1/de not_active IP Right Cessation
- 1992-01-31 DE DE69201725T patent/DE69201725T2/de not_active Expired - Lifetime
- 1992-01-31 HU HU9302407A patent/HU215124B/hu not_active IP Right Cessation
- 1992-01-31 CA CA002101275A patent/CA2101275C/en not_active Expired - Lifetime
- 1992-01-31 RU RU93054017A patent/RU2113848C1/ru not_active IP Right Cessation
- 1992-01-31 EP EP92908494A patent/EP0573604B1/de not_active Expired - Lifetime
- 1992-02-25 NZ NZ241717A patent/NZ241717A/en not_active IP Right Cessation
- 1992-02-25 IE IE920584A patent/IE65963B1/en not_active IP Right Cessation
-
1993
- 1993-01-25 US US08/008,859 patent/US6329354B1/en not_active Expired - Lifetime
- 1993-08-26 NO NO933044A patent/NO305581B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
NO933044L (no) | 1993-08-26 |
DE69201725T2 (de) | 1996-04-18 |
JP3727332B2 (ja) | 2005-12-14 |
NZ241717A (en) | 1997-02-24 |
ES2069424T3 (es) | 1995-05-01 |
RU2113848C1 (ru) | 1998-06-27 |
HU215124B (hu) | 1998-09-28 |
CZ282609B6 (cs) | 1997-08-13 |
DE69201725D1 (de) | 1995-04-20 |
JPH06505501A (ja) | 1994-06-23 |
HU9302407D0 (en) | 1993-11-29 |
CA2101275A1 (en) | 1992-08-27 |
DK0573604T3 (da) | 1995-05-29 |
KR100240358B1 (ko) | 2000-02-01 |
ATE119777T1 (de) | 1995-04-15 |
AU664368B2 (en) | 1995-11-16 |
WO1992014474A1 (en) | 1992-09-03 |
EP0573604B1 (de) | 1995-03-15 |
NO933044D0 (no) | 1993-08-26 |
SK90093A3 (en) | 1994-09-07 |
CA2101275C (en) | 1998-08-04 |
EP0573604A1 (de) | 1993-12-15 |
AU1643392A (en) | 1992-09-15 |
US6329354B1 (en) | 2001-12-11 |
IE65963B1 (en) | 1995-11-29 |
CZ175593A3 (en) | 1994-04-13 |
HUT66429A (en) | 1994-11-28 |
IE920584A1 (en) | 1992-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO305581B1 (no) | Anvendelse av et benaktivt fosfonat i kombinasjon med et °strogenhormon, og preparat i enhetsdoseform for behandling av osteoporose | |
CA2285203A1 (en) | Compositions containing capsaicin or capsaicin analogues and a local anesthetic | |
RU93054017A (ru) | Способ лечения остеопороза, композиция для лечения остеопороза, применение активно действующего на кости фосфоната и эстрогенного гормона для лечения остеопороза | |
NZ504026A (en) | Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C | |
ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
ES2055911T3 (es) | Compuesto farmaceutico adelgazante. | |
RU94046316A (ru) | Применение высокоэффективных фосфонатов при изготовлении лекарственных средств для лечения остеопороза | |
PT946151E (pt) | Forma de dosagem de dose crescente | |
DE69634357D1 (de) | Formulierungen mit dem wasserfreien mononatriumsalz von alendronat und deren verwendung zur behandlung von knochenkrankheiten | |
ATE218350T1 (de) | Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen | |
ES2114851T3 (es) | Utilizacion de composiciones de liberacion sostenida que contienen gnrh, lhrh o derivados de las mismas. | |
DE69316013D1 (de) | Verwendung von phosphinate zur behandlung der osteoporose | |
DE69420776D1 (de) | Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer | |
ATE88633T1 (de) | Verwendung von bestimmten calcium-citrate-malaten zur herstellung einer pharmazeutischen zubereitung fuer die behandlung von osteoporose. | |
ATE306278T1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
DE60120371D1 (de) | Verwendung von wachstumshormon in niederen dosen |